Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 18,336 shares at $125.02 ($2.3M) on 2022-11-03, disclosed to the SEC on 2022-11-04.
Open-market sale of $2.3M NBIX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.00 | 400 | $50K | 2.2% |
| 2 | $125.02 | 8,968 | $1.1M | 48.9% |
| 3 | $125.02 | 8,968 | $1.1M | 48.9% |
| Total | $125.02 avg | 18,336 | $2.3M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |